PP
TGTX icon

Pingora Partners’s TG Therapeutics TGTX Stock Holding History

Pingora Partners’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
2,200
-500
-19% -$20.5K 0.07% 95
2026
Q1 		$89.7K Buy
2,700
+600
+29% +$17.9K 0.05% 104
2025
Q4 		$62.6K Buy
2,100
+500
+31% +$16.3K 0.04% 113
2025
Q3 		$57.8K Hold
1,600
– – 0.04% 113
2025
Q2 		$57.6K Hold
1,600
– – 0.04% 112
2025
Q1 		$63.1K Hold
1,600
– – 0.05% 105
2024
Q4 		$48.2K Hold
1,600
– – 0.03% 130
2024
Q3 		$37.4K Hold
1,600
– – 0.03% 151
2024
Q2 		$28.5K Hold
1,600
– – 0.02% 163
2024
Q1 		$24.3K Hold
1,600
– – 0.02% 181
2023
Q4 		$27.3K Buy
+1,600
New +$18.6K 0.02% 128

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pingora Partners's TGTX Position: Q2 2026 in Review

Pingora Partners reduced its TG Therapeutics (TGTX) stake by 19% in Q2 2026, selling an estimated $20.5K and leaving 2,200 shares worth $121K. The position accounts for 0.07% of the portfolio, ranked #95.

Pingora Partners first reported a position in TGTX in Q4 2023 and has held it in 11 quarters since. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Pingora Partners held 2,200 shares of TG Therapeutics worth $121K as of Q2 2026.
  • Pingora Partners sold 500 TG Therapeutics shares in Q2 2026, an estimated $20.5K.
  • TG Therapeutics made up 0.07% of Pingora Partners's portfolio in Q2 2026, its #95 holding.
  • Pingora Partners first reported a position in TG Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.